Future Oncology
Volume 17, 2021 - Issue 30
Open access
5,018
Views
8
CrossRef citations to date
0
Altmetric
Plain Language Summary of Publication
A Plain Language Summary of the ASCENT Study: Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer
Aditya Bardia1 Massachusetts General Hospital Cancer Center,Harvard Medical School,Boston,
MA,
USAView further author information
, Sara A Hurvitz2 University of California, Los Angeles,Jonsson Comprehensive Cancer Center,Los Angeles,
CA,
USAView further author information
, Hope S Rugo3 University of California, San Francisco,Helen Diller Family Comprehensive Cancer Center,San Francisco,
CA,
USAView further author information
, Adam Brufsky4 Magee-Women’s Hospital and the Hillman Cancer Center,University of Pittsburgh Medical Center,Pittsburgh,
PA,
USAView further author information
, Javier Cortes5 International Breast Cancer Center (IBCC),Quiron Group,Barcelona,
SpainView further author information
, Sibylle Loibl6 Department of Medicine and Research,Hämatologisch-Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus,Frankfurt,
GermanyView further author information
, M Piccart7 Institut Jules Bordet,Université libre de Bruxelles,Brussels,
BelgiumView further author information
, Janice Cowden8 Patient authorView further author information
, Patty Spears8 Patient author;9 University of North Carolina Lineberger Comprehensive Cancer Center,Chapel Hill,
NC,
USAView further author information
& Lisa A Carey10 Department of Medicine – Division of Hematology/Oncology,University of North Carolina Lineberger Comprehensive Cancer Center,Chapel Hill,
NC,
USAView further author information
show all
Pages 3911-3924
|
Received 12 Jul 2021, Accepted 11 Aug 2021, Published online: 01 Sep 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.